Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Dec;62(6):971–975. doi: 10.1038/bjc.1990.419

Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer.

P Whitford 1, E A Mallon 1, W D George 1, A M Campbell 1
PMCID: PMC1971553  PMID: 2124138

Abstract

In 31 patients with carcinoma of the breast the phenotype and activation status of tumour infiltrating lymphocytes (TILs) was analysed by flow cytometry. The predominant cells, in all patients, were T lymphocytes and in the majority of cases CD8+ (cytotoxic/suppressor) T lymphocytes were present in greater numbers than CD4+ (helper) T lymphocytes. There was no relationship between the degree of lymphocytic infiltration and either tumour stage or grade but there appeared to be an inverse correlation with the levels of oestrogen receptor (ER) in the tumour (P less than 0.01). Both populations of T cells had significantly higher numbers of cells carrying HLA DR (class II major histocompatibility antigen) than the equivalent populations in peripheral blood from the same patient group (P less than 0.001). The transferrin receptor was found on similar numbers of CD8+ T cells in peripheral blood and among the tumour infiltrating lymphocytes while more of the CD4+ T cells infiltrating the tumour were found to carry this receptor (P = 0.034). The Tac (CD 25) antigen was also on similar numbers of CD8+ T cells from both peripheral blood and the tumour but was on fewer of the CD4+ T cells in the tumour with respect to peripheral blood (P = 0.029). In both TILs and blood lymphocytes, the Tac antigen was consistently present on greater numbers of CD4+ T lymphocytes than on the CD8+ T lymphocytes (P less than 0.001) and as this is a component of the interleukin 2 (IL-2) receptor this may be of relevance to the use of IL-2 in TIL cancer therapy.

Full text

PDF
971

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. An T., Sood U., Pietruk T., Cummings G., Hashimoto K., Crissman J. D. In situ quantitation of inflammatory mononuclear cells in ductal infiltrating breast carcinoma. Relation to prognostic parameters. Am J Pathol. 1987 Jul;128(1):52–60. [PMC free article] [PubMed] [Google Scholar]
  2. BERG J. W. Inflammation and prognosis in breast cancer; a search for host resistance. Cancer. 1959 Jul-Aug;12(4):714–720. doi: 10.1002/1097-0142(195907/08)12:4<714::aid-cncr2820120414>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  3. BLACK M. M., OPLER S. R., SPEER F. D. Survival in breast cancer cases in relation to the structure of the primary tumor and regional lymph nodes. Surg Gynecol Obstet. 1955 May;100(5):543–551. [PubMed] [Google Scholar]
  4. BLOOM H. J., RICHARDSON W. W. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957 Sep;11(3):359–377. doi: 10.1038/bjc.1957.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Belldegrun A., Muul L. M., Rosenberg S. A. Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity. Cancer Res. 1988 Jan 1;48(1):206–214. [PubMed] [Google Scholar]
  6. Ben-Ezra J., Sheibani K. Antigenic phenotype of the lymphocytic component of medullary carcinoma of the breast. Cancer. 1987 Jun 15;59(12):2037–2041. doi: 10.1002/1097-0142(19870615)59:12<2037::aid-cncr2820591212>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  7. Bhan A. K., DesMarais C. L. Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer. J Natl Cancer Inst. 1983 Sep;71(3):507–516. [PubMed] [Google Scholar]
  8. Bilik R., Mor C., Hazaz B., Moroz C. Characterization of T-lymphocyte subpopulations infiltrating primary breast cancer. Cancer Immunol Immunother. 1989;28(2):143–147. doi: 10.1007/BF00199115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Edwards P. A. Heterogeneous expression of cell-surface antigens in normal epithelia and their tumours, revealed by monoclonal antibodies. Br J Cancer. 1985 Feb;51(2):149–160. doi: 10.1038/bjc.1985.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Eremin O., Coombs R. R., Ashby J. Lymphocytes infiltrating human breast cancers lack K-cell activity and show low levels of NK-cell activity. Br J Cancer. 1981 Aug;44(2):166–176. doi: 10.1038/bjc.1981.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Eremin O., Coombs R. R., Prospero T. D., Plumb D. T-lymphocyte and B-lymphocyte subpopulations infiltrating human mammary carcinomas. J Natl Cancer Inst. 1982 Jul;69(1):1–8. [PubMed] [Google Scholar]
  12. Giorno R. Mononuclear cells in malignant and benign human breast tissue. Arch Pathol Lab Med. 1983 Aug;107(8):415–417. [PubMed] [Google Scholar]
  13. Göttlinger H. G., Rieber P., Gokel J. M., Lohe K. J., Riethmüller G. Infiltrating mononuclear cells in human breast carcinoma: predominance of T4+ monocytic cells in the tumor stroma. Int J Cancer. 1985 Feb 15;35(2):199–205. doi: 10.1002/ijc.2910350210. [DOI] [PubMed] [Google Scholar]
  14. Heo D. S., Whiteside T. L., Johnson J. T., Chen K. N., Barnes E. L., Herberman R. B. Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck. Cancer Res. 1987 Dec 1;47(23):6353–6362. [PubMed] [Google Scholar]
  15. Horny H. P., Horst H. A. Lymphoreticular infiltrates in invasive ductal breast cancer. A histological and immunohistological study. Virchows Arch A Pathol Anat Histopathol. 1986;409(2):275–286. doi: 10.1007/BF00708334. [DOI] [PubMed] [Google Scholar]
  16. Hurlimann J., Saraga P. Mononuclear cells infiltrating human mammary carcinomas: immunohistochemical analysis with monoclonal antibodies. Int J Cancer. 1985 Jun 15;35(6):753–762. doi: 10.1002/ijc.2910350610. [DOI] [PubMed] [Google Scholar]
  17. Itoh K., Tilden A. B., Balch C. M. Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas. Cancer Res. 1986 Jun;46(6):3011–3017. [PubMed] [Google Scholar]
  18. Maccarty W. C. LONGEVITY IN CANCER: A STUDY OF 293 CASES. Ann Surg. 1922 Jul;76(1):9–12. [PMC free article] [PubMed] [Google Scholar]
  19. Miescher S., Stoeck M., Qiao L., Barras C., Barrelet L., von Fliedner V. Proliferative and cytolytic potentials of purified human tumor-infiltrating T lymphocytes. Impaired response to mitogen-driven stimulation despite T-cell receptor expression. Int J Cancer. 1988 Nov 15;42(5):659–666. doi: 10.1002/ijc.2910420504. [DOI] [PubMed] [Google Scholar]
  20. RICHARDSON W. W. Medullary carcinoma of the breast; a distinctive tumour type with a relatively good prognosis following radical mastectomy. Br J Cancer. 1956 Sep;10(3):415–423. doi: 10.1038/bjc.1956.48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rabinowich H., Cohen R., Bruderman I., Steiner Z., Klajman A. Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes. Cancer Res. 1987 Jan 1;47(1):173–177. [PubMed] [Google Scholar]
  22. Rios A. M., Miller F. R., Heppner G. H. Characterization of tumor-associated lymphocytes in a series of mouse mammary tumor lines with differing biological properties. Cancer Immunol Immunother. 1983;15(2):87–91. doi: 10.1007/BF00199696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Robb R. J., Rusk C. M., Yodoi J., Greene W. C. Interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptors. Proc Natl Acad Sci U S A. 1987 Apr;84(7):2002–2006. doi: 10.1073/pnas.84.7.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rosenberg S. A., Lotze M. T., Yang J. C., Aebersold P. M., Linehan W. M., Seipp C. A., White D. E. Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Ann Surg. 1989 Oct;210(4):474–485. doi: 10.1097/00000658-198910000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Rosenberg S. A., Packard B. S., Aebersold P. M., Solomon D., Topalian S. L., Toy S. T., Simon P., Lotze M. T., Yang J. C., Seipp C. A. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. N Engl J Med. 1988 Dec 22;319(25):1676–1680. doi: 10.1056/NEJM198812223192527. [DOI] [PubMed] [Google Scholar]
  26. Rowe D. J., Beverley P. C. Characterisation of breast cancer infiltrates using monoclonal antibodies to human leucocyte antigens. Br J Cancer. 1984 Feb;49(2):149–159. doi: 10.1038/bjc.1984.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Slocum H. K., Pavelic Z. P., Rustum Y. M., Creaven P. J., Karakousis C., Takita H., Greco W. R. Characterization of cells obtained by mechanical and enzymatic means from human melanoma, sarcoma, and lung tumors. Cancer Res. 1981 Apr;41(4):1428–1434. [PubMed] [Google Scholar]
  28. Smith K. A. The interleukin 2 receptor. Annu Rev Cell Biol. 1989;5:397–425. doi: 10.1146/annurev.cb.05.110189.002145. [DOI] [PubMed] [Google Scholar]
  29. Tsudo M., Kozak R. W., Goldman C. K., Waldmann T. A. Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9694–9698. doi: 10.1073/pnas.83.24.9694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Underwood J. C., Giri D. D., Rooney N., Lonsdale R. Immunophenotype of the lymphoid cell infiltrates in breast carcinomas of low oestrogen receptor content. Br J Cancer. 1987 Dec;56(6):744–746. doi: 10.1038/bjc.1987.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Vose B. M., Gallagher P., Moore M., Schofield P. F. Specific and non-specific lymphocyte cytotoxicity in colon carcinoma. Br J Cancer. 1981 Dec;44(6):846–855. doi: 10.1038/bjc.1981.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Whiteside T. L., Miescher S., Hurlimann J., Moretta L., von Fliedner V. Separation, phenotyping and limiting dilution analysis of T-lymphocytes infiltrating human solid tumors. Int J Cancer. 1986 Jun 15;37(6):803–811. doi: 10.1002/ijc.2910370602. [DOI] [PubMed] [Google Scholar]
  33. Whitwell H. L., Hughes H. P., Moore M., Ahmed A. Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease. Br J Cancer. 1984 Feb;49(2):161–172. doi: 10.1038/bjc.1984.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Zuk J. A., Walker R. A. Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast. J Pathol. 1987 Aug;152(4):275–285. doi: 10.1002/path.1711520406. [DOI] [PubMed] [Google Scholar]
  35. von Kleist S., Berling J., Bohle W., Wittekind C. Immunohistological analysis of lymphocyte subpopulations infiltrating breast carcinomas and benign lesions. Int J Cancer. 1987 Jul 15;40(1):18–23. doi: 10.1002/ijc.2910400105. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES